go-v.orgdoi

Pharmacogenomics of Cardiovascular Diseases: The Path to Precision Therapy

Georges M. Nemer, Nagham Nafiz Hendi · Pharmaceutical science. · 2023

  • DOI 10.5772/intechopen.113236
  • Publisher OpenAlex
  • Type book-chapter
  • Issued 2023

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Pharmaceutical science. · OpenAlex · book-chapter · 2023

Abstract

Cardiovascular diseases (CVD) represent a substantial global health burden, leading to significant morbidity and mortality rates. However, the efficacy and safety of CVD therapies are markedly influenced by individual variability in drug responses and adverse reactions, often attributable to genetic factors. This chapter discusses how pharmacogenomics impacts the safety and efficacy of cardiovascular therapies through advanced genetic testing methods, like genome-wide association studies, polygenic risk scores, and multi-omics analyses.

Additionally, the chapter addresses challenges and future perspectives, with a focus on the role of artificial intelligence and machine learning in integrating pharmacogenomics and genotype-based personalized interventions into the routine CVD care to improve long-term health outcomes.

Open the resolved locator · 10.5772/intechopen.113236

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 22:03 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.intechopen.com/chapters/88382
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.